WordNet

the univalent hydrocarbon radical C2H5 derived from ethane by the removal of one hydrogen atom (同)ethyl_group, ethyl radical

PrepTutorEJDIC

エチル / エチルの

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/11/02 17:45:33」(JST)

wiki en

Ethyl loflazepate^[1] (marketed under the brand names Meilax, Ronlax and Victan)^[2]^[3]^[4] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.^[5] In animal studies it was found to have low toxicity, although in rats evidence of pulmonary phospholipidosis occurred with pulmonary foam cells developing with long-term use of very high doses.^[6] Its elimination half-life is 51 hours - 103 hours.^[7] It's mechanism of action is similar to other benzodiazepines. Ethyl loflazepate also produces an active metabolite which is stronger than the parent compound.^[8] Ethyl loflazepate was designed to be a prodrug for descarboxyloflazepate, it's active metabolite. It is the active metabolite which is responsible for most of the pharmacological effects rather than ethyl loflazepate.^[9] The main metabolites of ethyl loflazepate are descarbethoxyloflazepate, loflazepate and 3-hydroxydescarbethoxyloflazepate.^[10] Accumulation of the active metabolites of ethyl loflazepate are not affected by those with renal failure or impairment.^[11] The symptoms of an overdose of ethyl loflazepate include sleepiness, agitation and ataxia. Hypotonia may also occur in severe cases. These symptoms occur much more frequently and severely in children.^[12] Death from therapeutic maintenance doses of ethyl loflazepate taken for 2 – 3 weeks has been reported in 3 elderly patients. The cause of death was asphyxia due to benzodiazepine toxicity.^[13] High doses of the antidepressant fluvoxamine may potentiate the adverse effects of ethyl loflazepate.^[14]

Ethyl loflazeplate is commercialized in Mexico, although is not very used, under the trade name Victan. It's officially approved for the following conditions:^[15]^[16]

Anxiety
Post-trauma anxiety
Anxiety associated with severe neuropathic pain.
Generalized anxiety disorder (GAD)
Anxiety "crisis"
Delirium tremens

References[edit]

^ DE Patent 2012190
^ Ba, BB; Iliadis, A; Durand, A; Berger, Y; Cano, JP (Oct 1988). "New approach in bioavailability study of two formulations of ethyl loflazepate". Arzneimittel-Forschung 38 (10): 1486–9. ISSN 0004-4172. PMID 2904268.
^ Ba, BB; Iliadis, A; Cano, JP (1989). "Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites". Annals of biomedical engineering 17 (6): 633–46. doi:10.1007/BF02367467. ISSN 0090-6964. PMID 2574017.
^ "Benzodiazepine Names". non-benzodiazepines.org.uk. Retrieved 2009-04-05.
^ Ueki, S; Watanabe, S; Yamamoto, T; Shibata, S; Shibata, K; Ohta, H; Ikeda, K; Kiyota, Y et al. (Nov 1983). "Behavioral effects of ethyl loflazepate and its metabolites". Nippon yakurigaku zasshi. Folia pharmacologica Japonica 82 (5): 395–409. doi:10.1254/fpj.82.395. ISSN 0015-5691. PMID 6142848. |displayauthors= suggested (help)
^ Mazue, G; Berthe, J; Newmann, AJ; Brunaud, M (Oct 1981). "A toxicologic evaluation of ethyl fluclozepate (CM 6912)". International journal of clinical pharmacology, therapy, and toxicology 19 (10): 453–72. ISSN 0174-4879. PMID 6116677.
^ Cautreels, W; Jeanniot, JP (Nov 1980). "Quantitative analysis of CM 6912 (ethyl loflazepate) and its metabolites in plasma and urine by chemical ionization gas chromatography mass spectrometry. Application to pharmacokinetic studies in man". Biomedical mass spectrometry 7 (11–12): 565–71. doi:10.1002/bms.1200071124. ISSN 0306-042X. PMID 6112027.
^ Sakai, Y; Namima, M (Apr 1985). "Inhibitory effect on 3H-diazepam binding and potentiating action on GABA of ethyl loflazepate, a new minor tranquilizer". Japanese journal of pharmacology 37 (4): 373–9. doi:10.1254/jjp.37.373. ISSN 0021-5198. PMID 2861304.
^ Chambon, JP; Perio, A; Demarne, H; Hallot, A; Dantzer, R; Roncucci, R; Bizière, K (1985). "Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities". Arzneimittel-Forschung 35 (10): 1573–7. ISSN 0004-4172. PMID 2866771.
^ Davi, H; Guyonnet, J; Sales, Y; Cautreels, W (1985). "Metabolism of ethyl loflazepate in the rat, the dog, the baboon and in man". Arzneimittel-Forschung 35 (7): 1061–5. ISSN 0004-4172. PMID 2864933.
^ Ba, BB; Iliadis, A; Durand, A; Berger, Y; Necciari, J; Cano, JP (1989). "Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man". Fundamental & clinical pharmacology 3 (1): 11–7. doi:10.1111/j.1472-8206.1989.tb00025.x. ISSN 0767-3981. PMID 2714728.
^ Pulce C, Mollon P, Pham E, Frantz P, Descotes J (April 1992). "Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children". Vet Hum Toxicol 34 (2): 141–3. ISSN 0145-6296. PMID 1354907.
^ Kamijo, Y; Hayashi, I; Nishikawa, T; Yoshimura, K; Soma, K (Mar 2005). "Pharmacokinetics of the active metabolites of ethyl loflazepate in elderly patients who died of asphyxia associated with benzodiazepine-related toxicity". Journal of analytical toxicology 29 (2): 140–4. ISSN 0146-4760. PMID 15902983.
^ Imanishi, T; Onozawa, K; Hayashi, A; Baba, J (Dec 2001). "Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines". Nippon yakurigaku zasshi. Folia pharmacologica Japonica 118 (6): 403–10. doi:10.1254/fpj.118.403. ISSN 0015-5691. PMID 11778459.
^ "Victan". saludzac.gob.mx/. Retrieved 2009-12-25.
^ "VICTAN". Farmacia Guerra. Retrieved 2009-12-25.

External links[edit]

(Japanese) Meilax Fine Granules

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における関節吸引または注射：手技および適応 joint aspiration or injection in adults technique and indications
2. 魚油と海洋由来オメガ3脂肪酸 fish oil and marine omega 3 fatty acids
3. 高トリグリセリド血症患者に対するアプローチ approach to the patient with hypertriglyceridemia
4. 筋骨格系の胸痛の治療 treatment of musculoskeletal chest pain
5. 成人における中等度および重度熱傷の救急治療 emergency care of moderate and severe thermal burns in adults

English Journal

Molecular modeling, simulation and virtual screening of ribosomal phosphoprotein P1 from Plasmodium falciparum.

Kumari S1, Mohana Priya A2, Lulu S1, Tauqueer M3.
Journal of theoretical biology.J Theor Biol.2014 Feb 21;343:113-9. doi: 10.1016/j.jtbi.2013.10.014. Epub 2013 Nov 7.
Ribosomal phosphoprotein P1 (RPP1) is acidic phosphoprotein which in association with neutral phosphoprotein P0 and acidic phosphoprotein P2 forms ribosomal P protein complex as (P1)2-P0-(P2)2. P protein is known to be immunogenic and has important role in protein translation. 3D structure of P1 is
PMID 24211527

Effects of ethyl loflazepate on refractory epilepsy in children.

Kanemura H1, Sano F, Sugita K, Aihara M.
Journal of child neurology.J Child Neurol.2011 Oct;26(10):1284-9. doi: 10.1177/0883073811405202. Epub 2011 May 18.
We evaluated the safety and efficacy of ethyl loflazepate in children with epilepsy. The study group comprised 21 outpatients (4 by generalized, 17 by localization-related) aged between 9 months and 17 years. Ethyl loflazepate was administered at a dose of 0.015 mg/kg/day twice daily. The final mean
PMID 21596702

[Introducing treatment for dissociative identity disorder].

Kitamura N.
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.Seishin Shinkeigaku Zasshi.2011;113(9):918-26.
This paper is a case presentation and study of the introduction of treatment for Dissociative Identity Disorder (DID). Since one manifestation of the pathology of DID is that sufferers avoid relying on others, at the start of treatment we try to stabilise the relationship between clinicians and pati
PMID 22117398

Japanese Journal

持続性心身安定剤(ロフラゼプ酸エチル)が著効した心因性勃起障害の1例

天野俊康,関雅也,今尾哲也,竹前克朗
日本性機能学会雑誌 = The japanese journal of Impotence Research 26(1), 33-36, 2011-06-30
NAID 10029401516

パロキセチンとロフラゼプ酸エチルが奏効した心因性味覚障害の検討

竹内康人,山崎裕,村田翼,佐藤淳,大内学,秦浩信,北川善政
北海道歯学雑誌 31(2), 106-111, 2010-12-15
味覚障害の原因のひとつに，うつ病などの心因性があることは広く知られているが，適切な診断，治療は確率されていない.そこで，最近当科で経験した2例の心因性と考えられた味覚障害症例を報告する.患者は，56歳男性，65歳女性で，主訴はそれぞれ，味覚低下，口内の塩味であった.病悩期間は，5か月，2週間であった.当科受診前に耳鼻咽喉科，歯科医院の受診歴があり，原因不明とされ，積極的治療は行われなかった.血液検 …
NAID 10028208702

六君子湯が有効であった呑気症の1症例

李光鐘,猪股裕紀洋,阿曽沼克弘 [他],岡島英明,山本栄和,白水泰昌,塚本千佳,吉井大貴
日本小児外科学会雑誌 46(6), 946-950, 2010-10-20
症例は精神発達遅滞のない4歳男児.腹痛,上腹部膨満を主訴として来院した.腹部単純X線写真で胃内に高度のガス貯留と小腸のびまん性のガス貯留が認められた.精査では閉塞性病変は認められなかった.起床後腹部ガス貯留が著明に増加する一方で,夜間就寝すると軽快することから呑気症(空気嚥下症)と診断された.ファモチジン,大建中湯内服では症状不変で,持続的に胃内容を排出する目的で経鼻胃管を留置した.胃内容の排出促 …
NAID 110007817468

Related Pictures

★リンクテーブル★

リンク元	「ロフラゼプ酸エチル」
関連記事	「ethyl」

「ロフラゼプ酸エチル」

Ethyl loflazepate
Systematic (IUPAC) name
	Ethyl 9-Chloro-6-(2-fluorophenyl)-3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraene-4-carboxylate
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy cat.	?
Legal status	Schedule IV (US)
Routes	Oral
Pharmacokinetic data
Bioavailability	?
Metabolism	Hepatic
Half-life	?
Excretion	Renal
Identifiers
CAS number	29177-84-2
ATC code	N05BA18
PubChem	CID 3299
DrugBank	DB01545
ChemSpider	3183
UNII	VJB5FW9W9J
KEGG	D01293
ChEMBL	CHEMBL1213460
Chemical data
Formula	C18H14ClFN2O3
Mol. mass	360.7
	SMILES FC1=CC=CC=C1C2=NC(C(OCC)=O)C(NC3=C2C=C(C=C3)Cl)=O;
	InChI InChI=1S/C18H14ClFN2O3/c1-2-25-18(24)16-17(23)21-14-8-7-10(19)9-12(14)15(22-16)11-5-3-4-6-13(11)20/h3-9,16H,2H2,1H3,(H,21,23) ; Key:CUCHJCMWNFEYOM-UHFFFAOYSA-N ;
(what is this?) (verify);

　　[★]

英: ethyl loflazepate
関: ジメトックス、スカルナーゼ、メイラックス、メデタックス、ロンラックス

「ethyl」

　　[★]

エチル

関: Et

[1] DE Patent 2012190

[2] Ba, BB; Iliadis, A; Durand, A; Berger, Y; Cano, JP (Oct 1988). "New approach in bioavailability study of two formulations of ethyl loflazepate". Arzneimittel-Forschung 38 (10): 1486–9. ISSN 0004-4172. PMID 2904268.

[3] Ba, BB; Iliadis, A; Cano, JP (1989). "Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites". Annals of biomedical engineering 17 (6): 633–46. doi:10.1007/BF02367467. ISSN 0090-6964. PMID 2574017.

[4] "Benzodiazepine Names". non-benzodiazepines.org.uk. Retrieved 2009-04-05.

[5] Ueki, S; Watanabe, S; Yamamoto, T; Shibata, S; Shibata, K; Ohta, H; Ikeda, K; Kiyota, Y et al. (Nov 1983). "Behavioral effects of ethyl loflazepate and its metabolites". Nippon yakurigaku zasshi. Folia pharmacologica Japonica 82 (5): 395–409. doi:10.1254/fpj.82.395. ISSN 0015-5691. PMID 6142848. |displayauthors= suggested (help)

[6] Mazue, G; Berthe, J; Newmann, AJ; Brunaud, M (Oct 1981). "A toxicologic evaluation of ethyl fluclozepate (CM 6912)". International journal of clinical pharmacology, therapy, and toxicology 19 (10): 453–72. ISSN 0174-4879. PMID 6116677.

[7] Cautreels, W; Jeanniot, JP (Nov 1980). "Quantitative analysis of CM 6912 (ethyl loflazepate) and its metabolites in plasma and urine by chemical ionization gas chromatography mass spectrometry. Application to pharmacokinetic studies in man". Biomedical mass spectrometry 7 (11–12): 565–71. doi:10.1002/bms.1200071124. ISSN 0306-042X. PMID 6112027.

[8] Sakai, Y; Namima, M (Apr 1985). "Inhibitory effect on 3H-diazepam binding and potentiating action on GABA of ethyl loflazepate, a new minor tranquilizer". Japanese journal of pharmacology 37 (4): 373–9. doi:10.1254/jjp.37.373. ISSN 0021-5198. PMID 2861304.

[9] Chambon, JP; Perio, A; Demarne, H; Hallot, A; Dantzer, R; Roncucci, R; Bizière, K (1985). "Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities". Arzneimittel-Forschung 35 (10): 1573–7. ISSN 0004-4172. PMID 2866771.

[10] Davi, H; Guyonnet, J; Sales, Y; Cautreels, W (1985). "Metabolism of ethyl loflazepate in the rat, the dog, the baboon and in man". Arzneimittel-Forschung 35 (7): 1061–5. ISSN 0004-4172. PMID 2864933.

[11] Ba, BB; Iliadis, A; Durand, A; Berger, Y; Necciari, J; Cano, JP (1989). "Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man". Fundamental & clinical pharmacology 3 (1): 11–7. doi:10.1111/j.1472-8206.1989.tb00025.x. ISSN 0767-3981. PMID 2714728.

[12] Pulce C, Mollon P, Pham E, Frantz P, Descotes J (April 1992). "Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children". Vet Hum Toxicol 34 (2): 141–3. ISSN 0145-6296. PMID 1354907.

[13] Kamijo, Y; Hayashi, I; Nishikawa, T; Yoshimura, K; Soma, K (Mar 2005). "Pharmacokinetics of the active metabolites of ethyl loflazepate in elderly patients who died of asphyxia associated with benzodiazepine-related toxicity". Journal of analytical toxicology 29 (2): 140–4. ISSN 0146-4760. PMID 15902983.

[14] Imanishi, T; Onozawa, K; Hayashi, A; Baba, J (Dec 2001). "Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines". Nippon yakurigaku zasshi. Folia pharmacologica Japonica 118 (6): 403–10. doi:10.1254/fpj.118.403. ISSN 0015-5691. PMID 11778459.

[15] "Victan". saludzac.gob.mx/. Retrieved 2009-12-25.

[16] "VICTAN". Farmacia Guerra. Retrieved 2009-12-25.

匿名

検索

案内

案内

ethyl loflazepate